Episteme Prognostics
About:
Episteme Prognostics is a precision medicine company developing therapeutic biomarkers for pancreatic cancer.
Website: https://www.epistemedx.com/
Description:
Episteme Prognostics is a precision medicine company that develops therapeutic biomarkers for pancreatic cancer. It predicts chemotherapy response and assesses the benefit of epigenetic therapy to pancreatic cancer patients.
Total Funding Amount:
$4.11M
Headquarters Location:
New York, New York, United States
Founded Date:
2019-01-01
Contact Email:
info(AT)epistemedx.com
Founders:
Steven Leach, Surajit Dhara
Number of Employees:
Last Funding Date:
2023-04-13
IPO Status:
Private
Industries:
© 2025 bioDAO.ai